Treatment of Alzheimer's disease with short- and long-term oral THA and lecithin: a double-blind study



	Full Text (PDF)
	Alert me when this article is cited
	Alert me if a correction is posted
	Citation Map



	Email this article to a Colleague
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new issues of the journal
	Add to My Articles & Searches
	Download to citation manager



	Citing Articles via HighWire
	Citing Articles via Google Scholar



	Articles by Fitten, L. J.
	Articles by Marshall, C.
	Search for Related Content



	PubMed Citation
	Articles by Fitten, L. J.
	Articles by Marshall, C.

Am J Psychiatry 1990; 147:239-242
Copyright © 1990 by American Psychiatric Association

REGULAR ARTICLES

Treatment of Alzheimer's disease with short- and long-term oral THA and lecithin: a double-blind study

LJ Fitten, KM Perryman, PL Gross, H Fine, J Cummins and C Marshall
VA Medical Center, Sepulveda, Calif 91343.

Ten Alzheimer's disease patients underwent a trial of oral tetrahydroaminoacridine (THA) and lecithin. After 3 inpatient weeks there was no clear therapeutic effect. Three of six patients able to continue in long-term treatment showed measurable cognitive improvement, but only one displayed clinically obvious improvement.

This article has been cited by other articles:

L. J. Fitten, F. Ortiz, D. W. Siembieda, J. O'Neill, E. Halgren, and A. Fisher
Reduction of Motoric Agitation and Restlessness by AF102B and Tacrine in the Macaque
J Neuropsychiatry Clin Neurosci, February 1, 1999; 11(1): 79 - 85.
[Abstract] [Full Text]

N. Qizilbash, A. Whitehead, J. Higgins, G. Wilcock, L. Schneider, M. Farlow, and for the Dementia Trialists' Collaboration
Cholinesterase Inhibition for Alzheimer Disease: A Meta-analysis of the Tacrine Trials
JAMA, November 25, 1998; 280(20): 1777 - 1782.
[Abstract] [Full Text] [PDF]

N. Matsuoka and T. G. Aigner
FK960 [N-(4-Acetyl-1-piperazinyl)-p-fluorobenzamide Monohydrate], a Novel Potential Antidementia Drug, Improves Visual Recognition Memory in Rhesus Monkeys: Comparison with Physostigmine
J. Pharmacol. Exp. Ther., March 1, 1997; 280(3): 1201 - 1209.
[Abstract] [Full Text]

N Maltby, G A Broe, H Creasey, A F Jorm, H Christensen, and W S Brooks
Efficacy of tacrine and lecithin in mild to moderate Alzheimer's disease: double blind trial
BMJ, April 2, 1994; 308(6933): 879 - 883.
[Abstract] [Full Text]

K. M. Perryman and L. J. Fitten
Quantitative EEG During a Double-Blind Trial of THA and Lecithin in Patients with Alzheimer's Disease
J Geriatr Psychiatry Neurol, July 1, 1991; 4(3): 127 - 133.
[Abstract] [PDF]

Get information about faster international access.